Intuitive Surgical, Inc.

Thank you for standing by and welcome to the Intuitive Surgical, Inc.' 's first quarter 2025 earnings release. At this time, all participants are in listen-only mode. After the speaker's presentation, there will be a question and answer session. To ask a question during this session, you'll need to press star 1-1 on your telephone. If your question has been answered and you'd like to remove yourself from the queue, simply press star 1-1 again. As a reminder, today's program is being recorded. And now I'd like to introduce your host for today's program, Dan Connolly, Head of Investor Relations at Intuitive Surgical. Please go ahead, sir.

Good afternoon, and welcome to Intuitive's first quarter earnings conference call. With me today, we have Gary Goodhart, our CEO, Dave Rosa, our president, and Jamie Samath, our CFO. Before we begin, I would like to inform you that comments mentioned on today's call may be deemed to contain forward-looking statements. Actual results may differ materially from those expressed or implied as a result of certain risks and uncertainties. These risks and uncertainties are described in detail in our Securities and Exchange Commission filings, including our most recent Form 10-K, filed on January 31, 2025, and Form 10-Q, filed on October 18, 2024. Our SEC filings can be found through our website or at the SEC's website. Investors are cautioned not to place undue reliance on such forward-looking statements. Please note that this conference call will be available for audio replay on our website at intuitive.com on the events section under our investor relations page. Today's press release and supplementary financial data tables have been posted to our website. Today's format will consist of providing you with highlights of our first quarter results as described in our press release announced earlier today. followed by a question and answer session. Gary will introduce the call and provide a business overview. Dave will present the quarter's business, operational, and clinical highlights. Jamie will provide a review of our financial results and procedure highlights. Then I will discuss our updated financial outlook for 2025. And finally, we will host a question and answer session. With that, I will turn the call over to Gary.

Thank you for joining us on the call today. Our business performed well in the first quarter of the year, with physicians using our products at the high end of our expectations, driven by strong procedure growth and core general surgery in the United States and strong procedures outside the United States. New system placements in the quarter were solid, with particular strength in the U.S. We're pleased with performance of each of our platforms, with continued adoption of DV5 and multiport, solid results in ion, and acceleration in procedures using our single port platform. Given the dynamic changes in trade policy, I'd like to describe our principles for navigating the current environment, rather than detailing any particular scenario. Our first priority is to assure supply of our products to our customers globally. We have spent years becoming a trusted provider of great products and services, and our first commitment is to maintaining this status for those who depend upon us. We believe that high-quality, minimally invasive care at industrial scale will remain a global need, regardless of trade policy, and our long-term opportunity remains robust. We will continue to manage the business for the long term and invest towards improvement in the quintuple aim. Given potential changes in our costs and our customers' costs across their enterprise, we do not plan reflexive changes to our pricing in that dynamic near-term environment. Our second priority will be to optimize our production costs and rebalance product flows within our existing manufacturing and supply chain footprint as policies begin to stabilize. Finally, we'll adjust our supply chain strategy and assess adjustments to our pricing when we see the signs of a durable planning environment for trade. I'll now turn the call over to Dave to take you through our product services and operating highlights. Dave?